Coronavirus and TBDate: 16 April 2020 Tags: Miscellaneous
With WHO underlining the importance of continuing prevention and treatment of Tuberculosis (TB) during the COVID-19 crisis, the current situation can also help to zero in on ‘missed out’ TB patients.
The WHO has said that there is a stronger case for concurrent testing for both conditions in these individuals even if the clinical conditions are different.
It is important that the progress made in TB prevention and care is not reversed by the COVID19 pandemic, adding that TB patients who have lung damage or chronic obstructive pulmonary disease may suffer from more severe illness if they are infected with COVID-19.
India accounts for 27 per cent of the world’s total TB patients and is among the top 8 countries with the highest number of TB cases.
In 2018, as many as 4.4 lakh people died of TB in India which is 29 per cent of the total 1.5 million deaths due to TB in the world. Out of total 7 million cases reported in 2018 across the world, India had 2.69 million cases, it missed out on tracking down 5.40 lakh cases.
Doctors claim that people suffering from TB and COVID-19 may have poorer treatment outcomes, especially if TB treatment is interrupted.
Health experts believe that because of the fear of the coronavirus several will step forward for testing since symptoms for TB – fever, cough and difficulty in breathing — are almost similar to coronavirus.
The medical examination then will help reveal their TB bacteria infection. The current situation can also help identify people with latent TB – who have the disease but no symptoms. According to WHO, there are 25 per cent patients with latent TB.